According to CoinMeta, TimesSquare Capital Management released a review of its growth strategy for the U.S. mid-cap market for the second quarter of 2026. The report indicates that the global market managed to cope with geopolitical and macroeconomic changes during the turbulent second quarter. In the small and mid-cap stock sector, the market favored companies with higher price-to-earnings ratios, lower quality, and higher risk. TimesSquare preferred healthcare stocks that offer new therapies to meet unmet needs, as these companies were able to command premium pricing.